Formal Bids Received for S21-S25881 - Approve an award to EKF Diagnostic, Inc. dba Stanbio Laboratory in an amount not to exceed $416,850.00 for HemoPoint® H2 systems and consumables for the Houston Health Department.
Specific Explanation:
The Houston Health Department Director and Chief Procurement Officer recommend that City Council approve an award to EKF Diagnostic, Inc. dba Stanbio Laboratory on its low bid in an amount not to exceed $416,850.00 for HemoPoint® H2 systems and consumables for the Houston Health Department. It is further requested that authorization be given to make purchases, as needed, for a 36-month period with two, one-year options. This award consists of approximately 2,350 boxes (200 test strips per box) of microcuvette test strips and rapid antibody test controls (set of six bottles per box) to be used in the HemoPoint® H2 systems. These test strips will be used by medical personnel to test the blood of patients participating in the Women, Infants, and Children (WIC) program for low iron levels (anemia) at City health clinics. The WIC policies and procedures requires blood testing for pregnant, breastfeeding, and postpartum women and at least once annually for the children between one and five years of age.
This project was advertised in accordance with the requirements of the State of Texas bid laws. Three prospective bidders downloaded the solicitation document from SPD's e-bidding website, and two were received as outlined below:
EKF Diagnostic, Inc. dba Stanbio Laboratory: Award on its low overall bid for Group I, Line Item Nos. 1, 2, and 3 (test strips, rapid antibody test controls, and HemoPoint® H2 systems) in an amount not to exceed $416,850.00.
|
Company
|
Total Amount
|
|
|
1.
|
EKF Diagnostic, Inc. dba Stanbio Laboratory
|
$416,850.00
|
|
|
2.
|
Fisher HealthCare
|
$502,807.75
|
|
M/WBE Participation:
Zero-Percentage Goal document approved by the Office of Business Opportunity.
Hire Houston First:
The proposed award requires compliance with the City's 'Hire Houston First' (HHF) ordinance that promotes economic opportunity for Houston businesses and supports job creation. In this case, EKF Diagnostic, Inc. dba Stanbio Laboratory does not meet the requirements for HHF designation; no HHF firms were within three percent.
Fiscal Note:
Funding for this item is included in the FY17 Adopted Budget. Therefore, no Fiscal Note is required as stated in the Financial Policy Ord. 2014-1078.
______________________________________ ___________________________________
John J. Gillespie, Chief Procurement Officer Department Approval Authority Signature
Finance/Strategic Procurement Division
Estimated Spending Authority
|
Department
|
FY17
|
Out Years
|
Total
|
|
Houston Health
|
$74,050.00
|
$ 342,800.00
|
$ 416,850.00
|